Millennium Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$33.7K Sell
2023
Q4
$40.2K Buy
2023
Q2
Sell
2023
Q1
$84K Buy
2022
Q4
$73K Buy
2022
Q3
$44K Buy
2022
Q2
$64K Sell
2022
Q1
$230K Sell
2021
Q4
$440K Sell
2021
Q3
$601K Sell
2021
Q2
$2.38M Buy
2021
Q1
$178K Buy
2020
Q4
Sell
2020
Q3
$70 Sell
2020
Q2
$2.38M Buy
2018
Q3
Sell
2018
Q2
$1.74M Buy